Biotech Pharmacon ASA of Norway has announced the successful placement of 9.5 million new shares with private investors thereby raising NOK 40 million (€5.45 million) in gross proceeds for product launch and development. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
